ScanBalt BioRegion - On Top of Europe

ScanBaltThe ScanBalt association reports that ScanBalt BioRegion at the end of 2006 hosts 2129 Life science companies including 671 biotech companies, 323 phama companies and 370 medical device companies.

The year 2006 brought some remarkable results in ScanBalt BioRegion. The year finished with the biggest ever deal between pharma and biotech with the Medicon Valley based company Genmap signing an agreement with GlaxoSmithKline, the value of which potentially could exceed $2.1 billion.

In the Baltic countries and Poland biotech and life sciences are growing. As an example of this positive development the Latvian BioTech Association was established in 2006 and several foreign biotech companies have during the year moved into the country.

General secretary Peter Frank, ScanBalt says "We find the development positive. Life sciences and biotechnology are strong drivers for creating a competitive knowledge based economy in the Baltic Sea Region able to compete with the US, Asia and others. At the same time it is a frontrunner for integration of the region.

However we should constantly focus on removing barriers for the mobility of human, financial and industrial resources within the Baltic Sea Region and work to attract resources from the outside.

In addition the regions needs to strengthen their regional clusters and promote collaboration between them.

By doing so we can realize the full positive potential of life sciences and biotechnology on the economy and at the same time solve problems within health, environment, food and agriculture".

For further information please contact general secretary Peter Frank at +45 35324146, Mob +45 27141078, e-mail This email address is being protected from spambots. You need JavaScript enabled to view it. or visit http://www.scanbalt.org

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...